ロード中...
Immunotherapy of Head and Neck Cancer: Current and Future Considerations
Patients with head and neck squamous cell carcinoma (HNSCC) are at considerable risk for death, with 5-year relative survival rates of approximately 60%. The profound multifaceted deficiencies in cell-mediated immunity that persist in most patients after treatment may be related to the high rates of...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Hindawi Publishing Corporation
2009
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2723756/ https://ncbi.nlm.nih.gov/pubmed/19680453 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2009/346345 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|